Hep C U Later

What Hep C U Later does

Hep C U Later is an NHS-commissioned public health initiative operating as part of the NHS Addictions Provider Alliance (NHS APA), a collaboration of 19 NHS Trusts across England that provide drug, alcohol, and gambling treatment services. Founded in January 2020 and led by Inclusion — part of Midlands Partnership University NHS Foundation Trust (MPFT) — the initiative runs a core team of approximately five people and works toward eliminating viral hepatitis in England by 2025, five years ahead of the WHO 2030 global target. Its operational model combines direct micro-elination support to NHS APA community drug and alcohol services (approximately 50 sites) with a national engagement programme that supplies CPD-accredited training, resources, podcasts, and educational content to health and social care professionals across general practice, antenatal, emergency departments, dentistry, pharmacy, and addiction services.

The initiative delivers four distinct programmes: (1) a Drug and Alcohol Services micro-elimination programme providing data analysis, pathway reviews, testing/treatment events, and quality improvement methodology within the NHS APA footprint; (2) an Engagement Programme providing CPD-accredited training, communications, and anti-stigma work to professionals across England; (3) Detect and Protect — a hepatitis B and D resources programme; and (4) Hep B Gone — a hepatitis B primary care toolkit under national development. Core diagnostic technology deployed includes Cepheid GeneXpert machines for point-of-care hepatitis C RNA testing and FibroScans for liver health assessment, with a QR-code integration to the NHS England national Hepatitis C Testing Portal. Reported outcomes include a 37% reduction in hepatitis C-related deaths, a 52% reduction in liver transplants, a 102% increase in drug-service testing, and a 140% increase in treatment access (74,000 people treated).

Hep C U Later is funded through two channels: NHS England Viral Hepatitis Elimination Programme commissioning covers the Drug and Alcohol Services programme and the Engagement Programme, while the hepatitis B programmes (Detect and Protect and Hep B Gone) are funded through Joint Working Agreements and grants from Gilead Sciences Ltd. All resources, training, and materials are provided free of charge to health and social care professionals and patients, making this a grant- and commission-funded public-sector health programme rather than a commercially monetised entity. Recognised with the HSJ Best Healthcare Analytics Project for the NHS (2023), the UKPHR Best Digital and Communications Initiative of the Year (2025), and the MPFT Brilliant You Delivering Through Partnership award (2025).

Name

Hep C U Later

Legal name

Hep C U Later

Website

https://hepculater.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Hep C U Later is an NHS-commissioned initiative, led by Inclusion (part of MPFT) within the NHS Addictions Provider Alliance, that supports hepatitis C micro-elimination across 19 NHS Trusts and ~50 community drug and alcohol services in England while expanding into hepatitis B primary care via Gilead-funded programmes, delivering free CPD training, resources, and testing-pathway support to health professionals.

Ownership category

akta.pro rank

Product category

Public Health Elimination Services

NAICS

Administration of Public Health Programs (92312), Health Care and Social Assistance (62)

SIC

Services-Health Services (8000)

akta.pro primary industry

Hepatology (Viral Hepatitis) (HLAKAGAC)

akta.pro secondary industries

Hepatology & Liver Disease (HLAKAEAB), Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

• Hepatitis C elimination
• Viral hepatitis services
• CPD accredited training
• Public health programmes
• Harm reduction services

Headquarters

HQ city

National (England)

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. NHS England Commissioning: Programme 1 (Drug and Alcohol Services) and Programme 2 (Engagement Programme) are commissioned by NHS England Viral Hepatitis Elimination Programme
2. Gilead Sciences Joint Working Agreement: Hepatitis B resources programmes (Detect and Protect and Hep B Gone) are funded through joint working agreements with Gilead Sciences Ltd

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Core offering

Hep C U Later is an NHS England-commissioned public health initiative that supports the elimination of viral hepatitis in England by delivering free CPD-accredited training, downloadable educational resources, testing and treatment pathway support, and micro-elimination programmes across community drug and alcohol services. It operates four programmes: the Drug and Alcohol Services Programme (micro-elimination in ~50 NHS APA community services), the Engagement Programme (communications, training, and anti-stigma work for health and social care professionals), Detect and Protect (hepatitis B and D resources with Gilead Sciences), and Hep B Gone (hepatitis B primary care toolkit).

Product overview

Hep C U Later is a multi-programme NHS health initiative focused on viral hepatitis elimination rather than a traditional software product company. The core offering consists of educational resources, CPD-accredited training modules, podcasts and videos, and downloadable materials that support healthcare professionals in hepatitis C and B elimination efforts. These resources are organized across four distinct programmes: the NHS APA Drug and Alcohol Services Programme (supporting micro-elimination in approximately 50 community drug and alcohol treatment services), the Engagement Programme (providing communications and training for health professionals across England), Detect and Protect (hepatitis B and D resource development with Gilead Sciences), and Hep B Gone (hepatitis B primary care toolkit). The Hep C U Later Resources Library serves as the central repository for all downloadable materials including fact sheets, leaflets, posters, toolkits, case studies, and newsletters, while the Podcasts and Videos Gallery provides audio-visual educational content featuring NHS programme leads.

Differentiator

Problem solved

Functional benefit

Brands

• Hep C U Later Engagement Programme: Programme focused on providing communications, training, awareness, and resources on Hepatitis C to health and social care professionals
• Detect and Protect
• Hep B Gone

Products and services

• Hep C U Later Resources Library A comprehensive archive of downloadable resources including fact sheets, leaflets, posters, TV screen graphics, toolkits, case studies, newsletters, and promotional materials supporting hepatitis C awareness and elimination efforts, made available free of charge to health and social care professionals and patients.
• CPD Accredited Training Modules Continuing professional development accredited educational modules for health and social care professionals covering hepatitis C testing, treatment, and elimination strategies, delivered free of charge.
• Podcasts and Videos Gallery Educational audio and video content featuring interviews with NHS England programme leads, coordinators, and healthcare professionals discussing hepatitis C elimination initiatives and best practices.
• Drug and Alcohol Services Programme Programme focused on micro-eliminating hepatitis C within NHS Addictions Provider Alliance community drug and alcohol treatment services, supporting data analysis, testing pathways, and treatment initiatives across approximately 50 services, delivered to NHS commissioners and trust providers.
• Engagement Programme Cross-NHS provider initiative providing communications, training, awareness resources, and professional engagement support for hepatitis C elimination across England, led by Inclusion, part of Midlands Partnership University NHS Foundation Trust.
• Detect and Protect - Hepatitis B and D Resources Programme developing and distributing hepatitis B and D resources to professionals, including leaflets, TV screen graphics, and infographic packs for use in reports, presentations, websites, and social media.
• Hep B Gone - Hepatitis B Primary Care Toolkit National hepatitis B primary care toolkit under development, providing pathways, educational resources, videos, CPD training, guidance and key information for primary care settings to effectively tackle hepatitis B.

Quantifiable outcome

• 37% reduction in deaths from hepatitis C including liver disease and cancer
• +5 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eight partnerships are on record, tiered core and major.

• NHS Addictions Provider Alliance (NHS APA)coreStrategic or Co-development Partner · 1 January 2020Hep C U Later is an initiative of the NHS APA, a collaboration of 19 NHS Trusts providing addiction services. The partnership focuses on micro-eliminating hepatitis C within community drug and alcohol treatment services across England.
• NHS EnglandcoreStrategic or Co-development PartnerCommissioned by NHS England Viral Hepatitis Elimination Programme to deliver drug and alcohol services programme and engagement programme for health professionals.
• Gilead SciencescoreStrategic or Co-development PartnerJoint Working Agreement for Hepatitis B resources (Detect and Protect programme) and financial grant for Hep B Gone primary care toolkit. Both hepatitis B programmes funded by Gilead Sciences.
• The Hepatitis C TrustmajorStrategic or Co-development PartnerCollaboration on hepatitis C elimination. The Hepatitis C Trust provides peer to peer mentoring and training, and both organisations work together in the Hepatitis C Drug Treatment Provider Forum.
• Midlands Partnership University NHS Foundation Trust (MPFT)coreStrategic or Co-development PartnerHep C U Later is led by Inclusion, part of MPFT. MPFT provides organisational infrastructure and support for the elimination programmes.
• UKHSA (UK Health Security Agency)majorStrategic or Co-development PartnerCollaborates with UKHSA in the fight to micro-eliminate hepatitis C nationally.
• Operational Delivery Networks (ODNs)majorStrategic or Co-development PartnerCollaborates with ODNs and Hepatology departments across England to coordinate hepatitis C elimination activities.
• NHS England Viral Hepatitis Elimination ProgrammecoreStrategic or Co-development PartnerCommissioning body for hepatitis C elimination work. The programme aims to eliminate hepatitis C ahead of the rest of the world by 2025.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Others

• BHIVA (British HIV Association): UK professional association for HIV clinicians. Relevant as an adjacent NHS-commissioned specialist body producing CPD-accredited training, guidelines, and professional engagement resources for blood-borne viruses - similar operational pattern, but in HIV rather than viral hepatitis.

Direct peers

• The Hepatitis C Trust: UK charity dedicated to hepatitis C elimination, providing peer-to-peer mentoring, training, and advocacy. Most direct peer - Hep C U Later explicitly collaborates with The Hepatitis C Trust in the Hepatitis C Drug Treatment Provider Forum, and both serve overlapping professional and patient audiences.
• Hepatitis B Foundation: US non-profit focused on hepatitis B education, research, and patient advocacy. Relevant as a peer for Hep C U Later's Detect and Protect and Hep B Gone hepatitis B programmes, given similar disease-specific mission and resource-distribution model.
• British Liver Trust: UK-wide liver health charity covering hepatitis C, hepatitis B, and broader liver disease. Comparable as a national non-profit delivering education, professional resources, and patient support in viral hepatitis and hepatology, with a similar free-resource distribution model.
• EC Australia (Eliminate Hepatitis C Australia): Australian research and implementation initiative driving hepatitis C elimination through community-based micro-elimination. Highly comparable as a national public-health programme targeting the same disease, with similar testing and treatment-in-community approaches.

Regional players

• National Viral Hepatitis Roundtable (US): US coalition of organisations working to eliminate viral hepatitis through policy, education, and community programmes. Comparable as a public-health advocacy and engagement network, with regional (US) rather than national (England) scope.

Broad incumbents

• World Hepatitis Alliance: Global not-for-profit representing people living with viral hepatitis, focused on advocacy, awareness, and policy. Comparable as a higher-level umbrella organisation working on hepatitis elimination, providing international context for Hep C U Later's England-focused micro-elimination work.

Emerging players

• Liver4Life: UK liver health non-profit addressing liver disease including viral hepatitis. Comparable as a smaller, UK-based, free-resource charity working in adjacent hepatology education and awareness for both professionals and patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hep-c-u-later

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hep C U Later